CLYM Earnings Date: Nov 11, 2026 (Estimated) — Climb Bio, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CLYM's next earnings date?
Climb Bio, Inc. (CLYM) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20.
How did CLYM do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Climb Bio, Inc. posted EPS of -$0.18 versus the -$0.21 estimate, a beat of 18.2%. Revenue was $0. The stock's 1-day post-earnings move was +12.3%.
How much does CLYM stock move after earnings?
CLYM beat EPS estimates in 3 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 3.3% (up or down) in the day after earnings.
About Climb Bio, Inc.
Climb Bio, Inc. is a biopharmaceutical firm dedicated to crafting therapeutic solutions for inflammatory diseases driven by autoimmune responses. Its primary investigational asset is budoprutug, an anti-CD19 monoclonal antibody. This treatment is being advanced for a range of autoimmune conditions, including systemic lupus erythematosus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The entity, established in 2018, officially rebranded as Climb Bio, Inc. in October 2024, having previously operated under the name Eliem Therapeutics, Inc. Its corporate headquarters are situated in Wilmington, Delaware.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.21 | -0.18 | +18.18% | $0 | ✅ Beat | +12.27% | +15.40% | +17.00% |
| 2026-05-07 | Q1 2026 | -0.30 | -0.20 | +33.33% | $0 | ✅ Beat | -2.54% | -6.63% | -13.67% |
| 2026-03-05 | Q4 2025 | -0.20 | -0.26 | -30.00% | $0 | ❌ Miss | +1.51% | +0.69% | -9.89% |
| 2025-11-06 | Q3 2025 | -0.15 | -0.19 | -26.67% | $0 | ❌ Miss | +1.56% | +0.00% | -10.42% |
| 2025-08-12 | Q2 2025 | -0.19 | -0.13 | +31.58% | $0 | ✅ Beat | -2.42% | +27.88% | +44.24% |
| 2025-03-25 | Q4 2024 | — | -0.13 | — | $0 | — | +0.00% | -7.69% | +0.00% |
| 2024-08-14 | Q2 2024 | — | -1.81 | — | $0 | — | -3.38% | -3.70% | +28.62% |
| 2024-05-15 | Q1 2024 | — | -0.06 | — | $0 | — | -2.44% | -4.27% | +6.11% |
Showing last 8 quarters.